MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Another Day, Another Medtech Deal

HealthpointCapital acquired a controlling interest in CrossRoads Extremity Systems.

HealthpointCapital will take a controlling interest in Memphis, TN-based CrossRoads Extremity Systems in exchange for providing access to operating capital for continued organic growth, market expansion, and bolt-on acquisitions.

Pixabay

In a month filled with medtech deal news, CrossRoads Extremity Systems reports a merger agreement with HealthpointCapital. 

HealthpointCapital will take a controlling interest in the Memphis, TN-based medical device company in exchange for providing access to operating capital for continued organic growth, market expansion, and bolt-on acquisitions.

Using advanced technology and materials since its inception in 2014, CrossRoads has differentiated itself in the foot and ankle sector with its Active Stabilization technology. The technology is designed to simultaneously offer enhanced stability with continuous compression, optimizing conditions for bone healing in fusion procedures. The company also offers a reprocessing service called EcoSmart that provides gamma sterilized, reusable instruments. The service is intended to reduce inefficiencies of traditional non-sterile instrument trays and eliminates the waste associated with disposable instruments.

“CrossRoads’ unique product platform, particularly its Active Stabilization technology and EcoSMART Service, made [it]  an attractive investment in the extremity sector, which continues to be one of the most rapidly growing segments of the musculoskeletal market,” said Mike Mogul, president and managing director of HealthpointCapital. “With our deep understanding of this space, CrossRoads’ exclusive technology made [it] a logical addition to our portfolio of rapidly growing companies.”

MB Venture Partners, a Memphis, TN-based investment firm, was the lead institutional investor in CrossRoads prior to the merger. Both MB Venture Partners and CrossRoads’ management team intend to remain significant investors.

500 characters remaining